Agreement regarding overcoming hypertension in the Asian Hypertension Society Network 2022

• Main Authors: Hoshide, Satoshi, Yamamoto, Koichi, Katsurada, Kenichi, Yano, Yuichiro, Nishiyama, Akira, Wang, Ji-Guang, Narasingan, S N, Verma, Narsingh, Erwinanto, Erwinanto, Turana, Yuda, Ihm, Sang Hyun, Park, Sungha, Hanafi, Nik Sherina, Chia, Yook Chin *, Unurjargal, Tsolmon, Siddique, Saulat, Ona, Deborah Ignacia D, Venketasubramanian, Narayanaswamy, Teo, Boon Wee, Constantine, Godwin, Kao, Hsien-Li, Hung, Chi-Sheng, Sukonthasarn, Apichard, Kunanon, Sirisawat, Minh, Huynh Van, Kario, Kazuomi, Node, Koichi, Itoh, Hiroshi, Rakugi, Hiromi
• Format: Article
• Language: English
• Published: Sprinter Nature 2023
• Subjects: RC Internal medicine
• Online Access: http://eprints.sunway.edu.my/2668/1/Chia%20Yook%20Chin_Agreement%20regarding%20overcoming%20hypertension%20in%20the%20Asian.pdf; http://eprints.sunway.edu.my/2668/; https://doi.org/10.1038/s41440-022-00994-1
• Institution: Sunway University

The global burden of hypertension has already been acknowledged. The reduction in blood pressure (BP) significantly reduces cardiovascular morbidity and mortality. Half of the world’s population is concentrated in Asia, and this proportion is expected to continue to increase. As the population ages, the number of people suffering from hypertension is also expected to increase. It is critical to address hypertension in Asia. To do so, it is necessary to establish a common direction for the control of hypertension within the Asian region. Within Asia, religions and cultures differ, and economic development differs from region to region. However, despite this diversity, things will not progress efficiently or in a certain direction unless certain rules are in place. After convening the International Society of Hypertension (ISH) 2022 in Kyoto, Japan, we would like to present the direction agreed upon by the regional hypertension societies toward the goal of addressing hypertension in Asia. In particular, we focused on three points: target BP, sodium restriction, and out-of-office BP measurement.